Home » Topics » Regulatory

Regulatory
RSS

Exelixis receives first regulatory approval of cobimetinib in Switzerland

Aug. 28, 2015

Tracleer approved in Japan for new digital ulcers in patients with systemic scleroderma

Aug. 26, 2015

Remicade approved in Japan for entero-Behcet's, neuro-Behcet's and vasculo-Behcet's disease

Aug. 25, 2015

Daiichi Sankyo announces Japanese approvals for supplementary indications

Aug. 25, 2015

FDA approves first treatment for hypoactive sexual desire disorder in women

Aug. 19, 2015

FDA approves Keveyis for primary hyperkalemic and hypokalemic periodic paralysis

Aug. 11, 2015

FDA approves Praluent to treat high LDL cholesterol

July 27, 2015

FDA approves Odomzo for locally advanced BCC

July 27, 2015

Evolocumab becomes first PCSK9 inhibitor approved in the world

July 22, 2015

FDA approves Rexulti for schizophrenia and major depressive disorder

July 13, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...